CanFite BioPharma

Israel
Petaẖ Tiqva, Central District, Israel, 49170

Company profile

CanFite BioPharma company profile

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.

Business identity

Contact email
[email protected]
Phone number
+97239241114
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
1994-01-01, Year

Headquarters

Postal code
49170
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
15
Total equity funding
$94.4M
Last funding
Post IPO Equity / $15M / 2025-07-28
Last equity funding
Post IPO Equity / $15M
Investors
5
Founders
1
Articles
85
Exited on
2012-10-02

Founders and investors

Founders

Pnina Fishman

Investors

Ascend Technology VenturesCybele HoldingsGiza Venture CapitalSCP Vitalife PartnersYozma Group